News & Articles

1 in 3 Phase II trials were terminated in 2024

The UG 100 offers a cost-effective and extremely low-error sequencing profile

By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.

Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine

New test format enhances commercialisation potential

As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease

Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency

Technology advances, coupled with collaborations between equipment makers and healthcare organizations, are improving early detection of blood cancers in Africa

Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide

With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users

Combining Singleron’s innovation in single-cell technologies with Hamilton’s expertise in laboratory automation, Tensor streamlines the single-cell sequencing process

Discover how VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences can be used to overcome key challenges associated with cell culture, including contamination, viability, and reproducibility.

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

Explore streamlined navigation, personalized recommendations, and expert support for preclinical products and research services.

The partnership aims to deliver instruments, reagents, and consumables to service laboratories, breeders, and researchers worldwide.

A high-performance, cost-effective brightfield-only solution with optional fluorescence upgrade, ideal for high-throughput labs seeking reproducibility and flexibility.

Incorporating a combination of advanced polymer sealing surfaces - Biotech Fluidics liquid distribution valves are completely biocompatible.

A compact benchtop optofluidic system with lower cost of ownership for broader research accessibility

Hungarian researchers have published their latest findings in the prestigious international journal Biomedicines. They show that deuterium depletion, when used as a complementary therapy in cancer treatment, can significantly increase patient survival rates and reduce cancer-related mortality by 75-80%.